Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1967 1
1970 1
1974 1
1975 1
1976 3
1977 5
1978 1
1979 5
1980 2
1981 6
1982 2
1983 9
1984 10
1985 7
1986 22
1987 21
1988 19
1989 18
1990 24
1991 19
1992 29
1993 35
1994 30
1995 26
1996 34
1997 48
1998 32
1999 55
2000 47
2001 55
2002 74
2003 58
2004 77
2005 77
2006 101
2007 103
2008 115
2009 142
2010 146
2011 146
2012 220
2013 252
2014 234
2015 224
2016 249
2017 290
2018 287
2019 334
2020 388
2021 497
2022 505
2023 448
2024 179

Text availability

Article attribute

Article type

Publication date

Search Results

5,061 results

Results by year

Filters applied: . Clear all
The following terms were ignored: %, %, %, %, %
The following terms were not found in PubMed: 22Powell, 20JT, 5BAuthor
Page 1
The EQ-5D and the EuroQol Group.
Lloyd A, Pickard AS. Lloyd A, et al. Value Health. 2019 Jan;22(1):21-22. doi: 10.1016/j.jval.2018.12.002. Value Health. 2019. PMID: 30661629 Free article. No abstract available.
The effectiveness of sertraline in alleviating uremic pruritus in hemodialysis patients: a randomized clinical trial.
Elsayed MM, Elgohary IE, Abdelhamid HHS, Zaki SA. Elsayed MM, et al. BMC Nephrol. 2023 Jun 3;24(1):155. doi: 10.1186/s12882-023-03212-3. BMC Nephrol. 2023. PMID: 37270517 Free PMC article. Clinical Trial.
TRIAL REGISTRATION: ClinicalTrials.gov NCT05341843. First registration date: 22/04/2022....
TRIAL REGISTRATION: ClinicalTrials.gov NCT05341843. First registration date: 22/04/2022....
Atlas Argentino de Calidad de Vida Relacionada con la Salud: Análisis de los datos de la Encuesta Nacional de Factores de Riesgo por Provincias.
Augustovski F, Rey-Ares L, Gibbons L. Augustovski F, et al. Value Health Reg Issues. 2013 Dec;2(3):398-404. doi: 10.1016/j.vhri.2013.10.006. Epub 2013 Dec 12. Value Health Reg Issues. 2013. PMID: 29702777 Free article. Spanish.
RESULTS: The survey included 41.392 subjects; the expanded population represented 96% of the adult population of Argentina. 8.82% of the population reported excellent health, 24.6% very good, 43.9% good and 22.3% regular or bad. 42.8% reported limitations in at least one o …
RESULTS: The survey included 41.392 subjects; the expanded population represented 96% of the adult population of Argentina. 8.82% of the pop …
7-(Benzyl-sulfan-yl)-5-(2-methoxy-phen-yl)-1,3-dimethyl-5,6-dihydro-pyrimido[4,5-d]pyrimidine-2,4(1H,3H)-dione.
Bazgir A, Faraji F. Bazgir A, et al. Acta Crystallogr Sect E Struct Rep Online. 2008 Aug 6;64(Pt 9):o1666. doi: 10.1107/S160053680802401X. Acta Crystallogr Sect E Struct Rep Online. 2008. PMID: 21201659 Free PMC article.
In the mol-ecule of the title compound, C(22)H(22)N(4)O(3)S, the benzene and phenyl rings are oriented at a dihedral angle of 88.72 (4). ...
In the mol-ecule of the title compound, C(22)H(22)N(4)O(3)S, the benzene and phenyl rings are oriented at a dihedral angle of …
Testing Nonmonotonicity in Health Preferences.
Abellan-Perpiñan JM, Martinez-Perez JE, Pinto-Prades JL, Sanchez-Martinez FI. Abellan-Perpiñan JM, et al. Med Decis Making. 2024 Jan;44(1):42-52. doi: 10.1177/0272989X231207814. Epub 2023 Nov 10. Med Decis Making. 2024. PMID: 37947086
Analysis performed by separate states shows that the mean rates of violations with choices and ranking are about 22% and 34%, respectively. We also find new evidence of preference reversals and some evidence-though scarce-of transitivity violations in choices. ...Our study …
Analysis performed by separate states shows that the mean rates of violations with choices and ranking are about 22% and 34%, respect …
Effect of Myopia Severity on the Health-Related Quality of Life in Children and Their Parents.
Han X, Ruan X, Zhang Y, Lin H, Zhang M, Tan X, Liu Z, Luo L, Liu Y. Han X, et al. Curr Eye Res. 2023 Dec;48(12):1189-1194. doi: 10.1080/02713683.2023.2250581. Epub 2023 Sep 1. Curr Eye Res. 2023. PMID: 37655440

METHODS: Cross-sectional study from October to November, 2021. Age and sex-matched children with binocular emmetropia (-0.5D < spherical equivalence [SE] < 0.5D), low myopia (-5.0D < SE -0.5D), and high myopia (SE -5.0D), as well as their parents, we

…

METHODS: Cross-sectional study from October to November, 2021. Age and sex-matched children with binocular emmetropia (-0.5D < sph

…
Patient satisfaction with cluneal nerve entrapment surgery.
Kim K, Kokubo R, Isu T, Morimoto D, Morita A. Kim K, et al. Acta Neurochir (Wien). 2022 Oct;164(10):2667-2671. doi: 10.1007/s00701-022-05344-1. Epub 2022 Aug 16. Acta Neurochir (Wien). 2022. PMID: 35972558
The numerical rating scale (NRS) for LBP, the Oswestry Disability Index (ODI) score, and the EuroQOL 5-dimension, 5-level (EQ-5D-5L) scale before and 6 months after the operation were compared. Using these scores, the treatment outcome was compared with the patients' preop …
The numerical rating scale (NRS) for LBP, the Oswestry Disability Index (ODI) score, and the EuroQOL 5-dimension, 5-level (EQ-5D-5L) …
Coded aperture snapshot hyperspectral light field tomography.
Zhao R, Cui Q, Wang Z, Gao L. Zhao R, et al. Opt Express. 2023 Oct 23;31(22):37336-37347. doi: 10.1364/OE.501844. Opt Express. 2023. PMID: 38017865 Free article.
Additionally, leveraging the snapshot 3D imaging capability of LIFT, our approach efficiently records a five-dimensional (5D) plenoptic function in a single snapshot....
Additionally, leveraging the snapshot 3D imaging capability of LIFT, our approach efficiently records a five-dimensional (5D) plenopt …
EQ-5D: a plea for accurate nomenclature.
Brooks R, Boye KS, Slaap B. Brooks R, et al. J Patient Rep Outcomes. 2020 Jul 3;4(1):52. doi: 10.1186/s41687-020-00222-9. J Patient Rep Outcomes. 2020. PMID: 32620995 Free PMC article.
Since 2009, EQ-5D has been available in three versions: EQ-5D-3L, EQ-5D-5L, and EQ-5D-Y, where 3L stands for three levels, 5L for five levels, and Y for youth. ...Two surveys - of arthritis applications, and 82 recent publications - found a variety of …
Since 2009, EQ-5D has been available in three versions: EQ-5D-3L, EQ-5D-5L, and EQ-5D-Y, where 3L stands for thr …
Nivolumab plus ipilimumab versus chemotherapy as first-line treatment in advanced non-small-cell lung cancer with high tumour mutational burden: patient-reported outcomes results from the randomised, open-label, phase III CheckMate 227 trial.
Reck M, Schenker M, Lee KH, Provencio M, Nishio M, Lesniewski-Kmak K, Sangha R, Ahmed S, Raimbourg J, Feeney K, Corre R, Franke FA, Richardet E, Penrod JR, Yuan Y, Nathan FE, Bhagavatheeswaran P, DeRosa M, Taylor F, Lawrance R, Brahmer J. Reck M, et al. Eur J Cancer. 2019 Jul;116:137-147. doi: 10.1016/j.ejca.2019.05.008. Epub 2019 Jun 11. Eur J Cancer. 2019. PMID: 31195357 Free article. Clinical Trial.
During treatment, mean changes from baseline with nivolumab + ipilimumab showed early, clinically meaningful improvements in LCSS ASBI/3-IGI and EQ-5D VAS/UI; with chemotherapy, symptoms and health-related quality of life remained stable (LCSS ASBI/3-IGI, EQ-5D UI) …
During treatment, mean changes from baseline with nivolumab + ipilimumab showed early, clinically meaningful improvements in LCSS ASBI/3-IGI …
5,061 results